Portfolio Companies
Portfolio Companies
Chiesi Ventures invests in innovative biotech companies developing treatments for rare diseases.
MIRUM PHARMACEUTICALS
Mirum Pharmaceuticals is developing a compound, maralixibat, to treat Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), genetic liver disorders that affect primarily children.
IPO on NASDAQ
CURASEN
CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases, including Parkinson’s Disease, Alzheimer’s Disease and less common neurodegenerative disorders.
4D MOLECULAR THERAPEUTICS
4D Molecular Therapeutics is a platform company focused on the discovery and development of novel adeno-associated virus (AAV) vectors for use in gene therapy products for the treatment of monogenetic disorders
IPO on NASDAQ
VELOSBIO
VelosBio, Inc. is an oncology focused biotechnology company which is developing antibody drug conjugates to target solid tumors and hematological cancers.
MERCK
AURA BIOSCIENCES
Aura Biosciences is an innovation-driven company focused on the development of drugs using tumor targeted Viral-like Nanoparticles.
IPO on NASDAQ
SENTIEN BIOTECH
Sentien Biotechnologies, Inc. is a late preclinical stage company developing novel approaches to cell therapy.
KEZAR LIFE SCIENCES
Kezar Life Sciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that target protein homeostasis.
IPO on NASDAQ
GLYCOMINE
Glycomine is developing therapies for congenital disorders of glycosylation by combining replacement therapies with intracellular delivery vehicles.
MINORYX THERAPEUTICS
MINORYX specializes in developing innovative treatments for Inborn Errors of Metabolism, a group of rare diseases of genetic origin with high unmet medical need.
RENEO
Reneo Pharmaceuticals is a San Diego-based, private biotechnology company focused on the identification and development of novel treatments for orphan diseases.